MediciNova
Develops in-licensed small molecules across neurodegenerative, metabolic, and fibrotic diseases.
$1.44
After-hours close0.00 (0.00%)
At close$1.44(+1.06%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.06 | — | — |
| Aug 2026 | −$0.06 | −$0.05 | +21.0% |
| May 2026 | −$0.06 | −$0.05 | +16.7% |
| Feb 2026 | −$0.10 | −$0.05 | +47.4% |
| Nov 2025 | −$0.08 | −$0.06 | +25.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.06 | — | — | $75.0K | — | — |
| Aug 13, 2026 | −$0.06 | −$0.05 | +21.0% | $75.0K | $459.0K | +512.0% |
| May 15, 2026 | −$0.06 | −$0.05 | +16.7% | $187.0K | $187.0K | 0.0% |
| Feb 20, 2026 | −$0.10 | −$0.05 | +47.4% | $151.7K | $151.0K | −0.5% |
| Nov 12, 2025 | −$0.08 | −$0.06 | +25.0% | — | $123.3K | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 13, 2025 | ||||||
| Feb 19, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Feb 15, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 16, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Feb 16, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Feb 18, 2021 | ||||||
| Oct 26, 2020 | ||||||
| Jul 28, 2020 | ||||||
| Apr 23, 2020 | ||||||
| Feb 13, 2020 | ||||||
| Oct 25, 2019 | ||||||
| Jul 25, 2019 | ||||||
| Apr 25, 2019 | ||||||
| Feb 13, 2019 | ||||||
| Oct 25, 2018 | ||||||
| Jul 23, 2018 | ||||||
| Apr 25, 2018 | ||||||
| Feb 13, 2018 | ||||||
| Oct 23, 2017 | ||||||
| Jul 26, 2017 | ||||||
| Apr 26, 2017 | ||||||
| Feb 14, 2017 | ||||||
| Oct 25, 2016 | ||||||
| Jul 26, 2016 | ||||||
| Apr 27, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Oct 29, 2015 | ||||||
| Jul 30, 2015 | ||||||